Prospective study of IL-18 and risk of MI and stroke in men and women aged 60-79years: A nested case-control study

Cytokine

Volumn 61, Issue 2, 2013, Pages 513-520

  Jefferis, Barbara J ^a   Whincup, Peter H ^b   Welsh, Paul ^c   Wannamethee, S Goya ^a   Rumley, Ann ^c   Ebrahim, Shah ^d   Lawlor, Debbie A ^e   Lowe, Gordon D O ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cohort; Coronary heart disease; Epidemiology; Interleukin 18; Stroke

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 18; INTERLEUKIN 6; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; FORCED EXPIRATORY VOLUME; HEART INFARCTION; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE;

AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-18; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; STROKE;

EID: 84873155122     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.10.010     Document Type: Article

References (26)

1. Mallat Z., Corbaz A., Scoazec A., Besnard S., Leseche G., Chvatchko Y., et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001, 104:1598-1603.
2. Gerdes N., Sukhova G.K., Libby P., Reynolds R.S., Young J.L., Schonbeck U. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 2002, 195:245-257.
3. Jefferis B.J., Papacosta O., Owen C.G., Wannamethee S.G., Humphries S.E., Woodward M., et al. Interleukin 18 and coronary heart disease: prospective study and systematic review. Atherosclerosis 2011, 217:227-233.
4. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913.
5. Lewington S., Whitlock G., Clarke R., Sherliker P., Emberson J., Halsey J., et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007, 370:1829-1839.
6. Welsh P., Woodward M., Rumley A., Lowe G. Associations of circulating TNFalpha and IL-18 with myocardial infarction and cardiovascular risk markers: the Glasgow Myocardial Infarction Study. Cytokine 2009, 47:143-147.
7. Troseid M., Seljeflot I., Hjerkinn E.M., Arnesen H. Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia. Diabetes Care 2009, 32:486-492.
8. Welsh P., Lowe G.D., Chalmers J., Campbell D.J., Rumley A., Neal B.C., et al. Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke 2008, 39:2226-2230.
9. Stott D.J., Welsh P., Rumley A., Robertson M., Ford I., Sattar N., et al. Adipocytokines and risk of stroke in older people: a nested case-control study. Int J Epidemiol 2008, 38:253-261.
10. Blankenberg S., McQueen M.J., Smieja M., Pogue J., Balion C., Lonn E., et al. Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2006, 114:201-208.
11. Walker M., Whincup P.H., Shaper A.G. The British Regional Heart Study 1975-2004. Int J Epidemiol 2004, 33:1185-1192.
12. Lawlor D.A., Bedford C., Taylor M., Ebrahim S. Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study. J Epidemiol Community Health 2003, 57:134-140.
13. Wannamethee S.G., Lowe G.D., Whincup P.H., Rumley A., Walker M., Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 2002, 105:1785-1790.
14. Danesh J., Kaptoge S., Mann A.G., Sarwar N., Wood A., Angleman S.B., et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 2008, 5:e78.
15. Emberson J.R., Whincup P.H., Morris R.W., Walker M., Lowe G.D., Rumley A. Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study. Eur J Cardiovasc Prev Rehabil 2004, 11:125-134.
16. World Health Organization Expert Committee. Hypertension and coronary heart disease: classification and criteria for epidemiological studies. 168. Geneva, World Health Organization. Technical report series; 1959.
17. Rosner B., Spiegelman D., Willett W.C. Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error. Am J Epidemiol 1992, 136:1400-1413.
18. Welsh P., Woodward M., Rumley A., Lowe G. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study. Br J Haematol 2008, 141:852-861.
19. Welsh P., Woodward M., Rumley A., MacMahon S., Lowe G.D. Does interleukin-18 or tumour necrosis factor-a have an independent association with the risk of coronary heart disease? Results from a prospective study in New Zealand. Cytokine 2010, 50:94-98.
20. Cesari M., Penninx B.W.J.H., Newman A.B., Kritchevsky S.B., Nicklas B.J., Sutton-Tyrrell K., et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC Study. Circulation 2003, 108:2317-2322.
21. Koenig W., Khuseyinova N., Baumert J., Thorand B., Loewel H., Chambless L., et al. Increased concentrations of C-Reactive Protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Arterioscler Thromb Vasc Biol 2006, 26:2745-2751.
22. Hung J., Knuiman M.W., Divitini M.L., Langton P.E., Chapman C.L., Beilby J.P. C-Reactive Protein and Interleukin-18 levels in relation to coronary heart disease: prospective cohort study from Busselton Western Australia. Heart, Lung Circula 2008, 17:90-95.
23. Thompson S.R., Novick D., Stock C.J., Sanders J., Brull D., Cooper J., et al. Free Interleukin (IL)-18 Levels, and the impact of IL18 and IL18BP genetic variation, in CHD patients and healthy men. Arterioscler Thromb Vasc Biol 2007, 27:2743-2749.
24. Tiret L., Godefroy T., Lubos E., Nicaud V., Tregouet D.A., Barbaux S., et al. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 2005, 112:643-650.
25. Ormstad H., Aass H.C., Lund-Sorensen N., Amthor K.F., Sandvik L. Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. J Neurol 2011, 258:677-685.
26. Zaremba J., Losy J. Interleukin-18 in acute ischaemic stroke patients. Neurol Sci 2003, 24:117-124.